Given the antiatherogenic effects of IGF-1 and beneficial effect of anti-inflammation strategy on atherosclerosis development, we developed an IGF-1-derived peptide modified by an anti-inflammatory drug, which has the characteristics of IGF-1 bioactivity, self-assembling, and enhanced anti-inflammatory property. Here, IGF1 is linked to atherosclerosis.